Tumor growth experiments. Three-month old mice were inoculated subcutaneously with 7x10 5 LLC1 cells or 1x10 6 B16F1 cells. Tumor dimensions were measured using a caliper and tumor volumes were calculated by the following formula assuming an ellipsoid shape: W 2 x c x π/6, where W=measured tumor width and L=measured tumor length (Tomayko and Reynolds, 1989) . Statistical analysis was performed by Student's t-test (two-tailed, equal variance). Mice were killed when the calculated tumor volume exceeded 1000 mm 3 or when tumors became necrotic.
Mouse endothelial cell culture. Aortic ECs were isolated from Pparb +/+ and Pparb -/-mice as described (Chen et al., 2004) and plated as primary cells on matrigel-coated 24-well plates in EGM-2 medium (Cambrex, Copenhagen, Denmark) at a density of 5,000 cells per well essentially as described. The purified preparations contained >96% ECs as determined by isolectin B4 lectin staining (Kawamoto et al., 2003) .
When confluent, cells were reseeded in 24-well plates (2500 cells/well) and cultured for up to 6 days in EGM-2 medium supplemented with growth factors provided with the medium. Cell growth was determined using a Z1 Coulter counter (100 µm aperture, 10 µm threshold). for mouse blood vessels, was performed as described (Kawamoto et al., 2003) . Slides were evaluated with a Leitz RMB 3 microscope using either bright field or fluorescence optics. Digital microphotographs were used for histomorphometric analysis (Spot-Cam, Diagnostic Instruments, Munich, Germany) and color composites were generated with Adobe Photoshop v6.0. For quantitative analysis at least ten 40x high power fields were analyzed. Statistical analysis was performed by Student's ttest (two-tailed, equal variance).
Establishment of fibroblasts from

Isolation and amplification of RNA
RNA was isolated using the Nucleospin RNA II kit (Macherey-Nagel, Düren, Germany). For microarray studies, mRNA samples were amplified using the MessageAmp™ II RNA Amplification Kit (Ambion, Huntingdon, UK) according to the manufacturer's instructions. The amplification procedure consists of reverse transcription with an oligo(dT) primer bearing a T7 promoter followed by in vitro transcription of the resulting cDNA with T7 RNA polymerase to generate multiple copies of each mRNA. After one round of in vitro transcription starting with 1 µg of total RNA, the yield of amplified mRNA ranged from 50 -100 µg. Prior to
